Followers | 2 |
Posts | 607 |
Boards Moderated | 0 |
Alias Born | 05/08/2020 |
Saturday, April 09, 2022 1:01:11 PM
Recent BTAI News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 08:05:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2024 11:00:27 AM
- BioXcel Therapeutics Announces Clinical Prioritization and Update on BXCL501 Late-Stage Programs for Agitation • GlobeNewswire Inc. • 09/19/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/17/2024 11:23:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/17/2024 11:21:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/17/2024 11:20:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/17/2024 11:18:35 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 09/17/2024 11:17:50 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/16/2024 09:42:59 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/16/2024 09:26:07 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/16/2024 09:16:32 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/16/2024 05:23:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 08:15:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2024 11:16:38 AM
- BioXcel Therapeutics Announces Initiation of SERENITY At-Home Pivotal Phase 3 Safety Trial of BXCL501 for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia • GlobeNewswire Inc. • 09/05/2024 11:00:00 AM
- BioXcel Therapeutics to Participate in Canaccord Genuity 44th Annual Growth Conference • GlobeNewswire Inc. • 08/07/2024 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 01:05:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 11:05:19 AM
- BioXcel Therapeutics Reports Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/06/2024 11:00:00 AM
- BioXcel Therapeutics to Report Second Quarter 2024 Financial Results on August 6, 2024 • GlobeNewswire Inc. • 07/30/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2024 08:41:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/16/2024 11:00:27 AM
- BioXcel Therapeutics Announces Preliminary Estimated Unaudited Second Quarter Net Revenues from Sales of IGALMI™ (dexmedetomidine) Sublingual Film • GlobeNewswire Inc. • 07/16/2024 11:00:00 AM
- BioXcel Therapeutics Announces Positive Topline Results from Post-Marketing Requirement Study Evaluating PRN Treatment of IGALMI™ (dexmedetomidine) Sublingual Film for Agitation Associated with Bipolar Disorders or Schizophrenia • GlobeNewswire Inc. • 06/25/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/19/2024 01:27:09 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM